Results     25-May-21
Announcements
Astrazeneca Pharma India standalone net profit rises 184.76% in the March 2021 quarter
Sales rise 7.88% to Rs 210.26 crore
Net profit of Astrazeneca Pharma India rose 184.76% to Rs 27.28 crore in the quarter ended March 2021 as against Rs 9.58 crore during the previous quarter ended March 2020. Sales rose 7.88% to Rs 210.26 crore in the quarter ended March 2021 as against Rs 194.90 crore during the previous quarter ended March 2020.

For the full year,net profit rose 29.19% to Rs 93.30 crore in the year ended March 2021 as against Rs 72.22 crore during the previous year ended March 2020. Sales declined 2.19% to Rs 813.56 crore in the year ended March 2021 as against Rs 831.81 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear Ended
 Mar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.
Sales210.26194.90 8 813.56831.81 -2
OPM %19.227.59 -16.6514.51 -
PBDT42.6817.89 139 147.22132.55 11
PBT36.8413.35 176 127.09113.97 12
NP27.289.58 185 93.3072.22 29

Previous News
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 10-Aug-21   10:00 )
  Astrazeneca Pharma India to announce Quarterly Result
 ( Corporate News - 30-Jan-21   10:12 )
  Volumes spurt at AIA Engineering Ltd counter
 ( Hot Pursuit - 12-Nov-20   11:00 )
  Astrazeneca Pharma India intimates of delay on termination of distribution arrangements for Menorem in India
 ( Corporate News - 28-Jul-17   10:26 )
  AstraZeneca moves up after reports of getting marketing nod for drug
 ( Hot Pursuit - 21-Jun-17   14:53 )
  Astrazeneca Pharma India to table results
 ( Corporate News - 31-Oct-23   14:03 )
  AstraZeneca hits 52-week high on DCGI nod for Dapagliflozin tablets
 ( Hot Pursuit - 25-Jul-23   15:00 )
  AstraZeneca India gets govt nod for import & sale of cancer-treating drug Enhertu
 ( Hot Pursuit - 04-May-23   11:28 )
  AstraZeneca Pharma India to launch cancer drug - Osimertinib Tablet
 ( Corporate News - 29-May-17   18:41 )
  Outcome of board meeting of AstraZeneca Pharma India
 ( Corporate News - 05-May-14   17:57 )
  Astrazeneca Pharma India net profit declines 34.74% in the March 2009 quarter
 ( Results - Announcements 23-Apr-09   16:14 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top